2025. Role of Rituximab as First Line Immunosuppressant in Primary Glomerulonephritis. Indus Journal of Bioscience Research. 3, 4 (Apr. 2025), 150–155. DOI:https://doi.org/10.70749/ijbr.v3i4.890.